A Qualitative Prospective Study to Compare the Effectiveness of Neostigmine Versus Sugammadex in Length of PACU Stay in ASA II and III Patients Undergoing Sleeve Gastrectomy Bariatric Surgery

Trial Profile

A Qualitative Prospective Study to Compare the Effectiveness of Neostigmine Versus Sugammadex in Length of PACU Stay in ASA II and III Patients Undergoing Sleeve Gastrectomy Bariatric Surgery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 May 2018

At a glance

  • Drugs Sugammadex (Primary) ; Neostigmine
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 19 Jan 2018 Planned End Date changed from 1 Aug 2018 to 1 Nov 2018.
    • 19 Jan 2018 Planned primary completion date changed from 15 Jul 2018 to 31 Oct 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top